71 min listen
Women in Genomics
ratings:
Length:
28 minutes
Released:
Jan 25, 2020
Format:
Podcast episode
Description
Like many areas of science, the early days of genomics quickly became a male-dominated discipline. While more women were earning advanced degrees and training in this area, fewer were finding a place in faculty and other leadership positions. Dr. Kellye Eversole and others developed a group to advance networking channels, provide career advice, and relay funding opportunities with the interest in connecting women scientists with others in genomics. For over twenty years this organization has helped to raise opportunities for women in genomics, especially early-career scientists. Their support has helped accelerate the careers of many women in science. Hosted by Modesta Abugu.www.womeningenomics.org On Twitter follow #womeningenomics Follow Modesta Abugu on Twitter The Talking Biotech Podcast is produced and funded by Kevin Folta outside of business hours. The information provided is that of the hosts, guests and producer, and is in no way intended to reflect the views of the University of Florida, its administration, faculty, staff, or students. # COLABRATalking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/# TALKING BIOTECHTwitter: https://twitter.com/talkingbiotechWebsite: https://www.colabra.app/podcasts/talking-biotech/Instagram: https://www.instagram.com/colabrahqThe Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
Released:
Jan 25, 2020
Format:
Podcast episode
Titles in the series (100)
Success or Failure? Good Study Called Bad, Bad Study Called Gold.: This week’s podcast is an important analysis of two published reports. First, the results from the famous Rothamstead wheat trial show that their transgene does not confer resistance to aphids, inconsistent with their laboratory findings. While this outc by Talking Biotech with Dr. Kevin Folta